id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-0288-0016,FDA,FDA-2015-D-0288,"Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical
Devices; Guidance for Industry and Food and Drug Administration Staff;
Availability",Notice,Notice of Availability,2015-12-15T05:00:00Z,2015,12,2015-12-15T05:00:00Z,,2015-12-15T15:30:27Z,2015-31407,0,0,0900006481da7326
FDA-2015-D-0288-0017,FDA,FDA-2015-D-0288,Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical Devices Guidance for Industry,Other,Guidance,2015-12-15T05:00:00Z,2015,12,2015-12-15T05:00:00Z,,2024-11-11T21:15:54Z,,1,0,0900006481daa527
FDA-2015-D-0288-0002,FDA,FDA-2015-D-0288,"Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical
Devices; Draft Guidance for Industry and Food and Drug Administration
Staff",Other,Guidance,2015-02-11T05:00:00Z,2015,2,2015-02-11T05:00:00Z,,2024-11-12T05:35:41Z,,1,0,09000064819ff604
FDA-2015-D-0288-0001,FDA,FDA-2015-D-0288,"Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical
Devices; Draft Guidance for Industry and Food and Drug Administration
Staff; Availability",Notice,Notice of Availability,2015-02-11T05:00:00Z,2015,2,2015-02-11T05:00:00Z,2015-05-13T03:59:59Z,2015-04-26T02:00:44Z,2015-02722,0,0,09000064819feae0